396 related articles for article (PubMed ID: 19508712)
21. Effectiveness of a patient-centred, empowerment-based intervention programme among patients with poorly controlled type 2 diabetes: A randomised controlled trial.
Cheng L; Sit JWH; Choi KC; Chair SY; Li X; Wu Y; Long J; Tao M
Int J Nurs Stud; 2018 Mar; 79():43-51. PubMed ID: 29149618
[TBL] [Abstract][Full Text] [Related]
22. Self-titration of insulin in the management of people with type 2 diabetes: a practical solution to improve management in primary care.
Khunti K; Davies MJ; Kalra S
Diabetes Obes Metab; 2013 Aug; 15(8):690-700. PubMed ID: 23253563
[TBL] [Abstract][Full Text] [Related]
23. Initiation of insulin glargine in suboptimally controlled patients with type 2 diabetes: sub-analysis of the AT.LANTUS trial comparing treatment outcomes in subjects from primary and secondary care in the UK.
Davies M; Evans R; Storms F; Gomis R; Khunti K
Diabetes Obes Metab; 2007 Sep; 9(5):706-13. PubMed ID: 17697063
[TBL] [Abstract][Full Text] [Related]
24. Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial.
Zinman B; Fulcher G; Rao PV; Thomas N; Endahl LA; Johansen T; Lindh R; Lewin A; Rosenstock J; Pinget M; Mathieu C
Lancet; 2011 Mar; 377(9769):924-31. PubMed ID: 21396703
[TBL] [Abstract][Full Text] [Related]
25. Diabetes patients' experiences with the implementation of insulin therapy and their perceptions of computer-assisted self-management systems for insulin therapy.
Simon AC; Gude WT; Holleman F; Hoekstra JB; Peek N
J Med Internet Res; 2014 Oct; 16(10):e235. PubMed ID: 25340869
[TBL] [Abstract][Full Text] [Related]
26. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.
Farmer AJ; Wade AN; French DP; Simon J; Yudkin P; Gray A; Craven A; Goyder L; Holman RR; Mant D; Kinmonth AL; Neil HA;
Health Technol Assess; 2009 Feb; 13(15):iii-iv, ix-xi, 1-50. PubMed ID: 19254484
[TBL] [Abstract][Full Text] [Related]
27. Study rationale and design of the CIMT trial: the Copenhagen Insulin and Metformin Therapy trial.
Lundby Christensen L; Almdal T; Boesgaard T; Breum L; Dunn E; Gade-Rasmussen B; Gluud C; Hedetoft C; Jarloev A; Jensen T; Krarup T; Johansen LB; Lund SS; Madsbad S; Mathiesen E; Moelvig J; Nielsen F; Perrild H; Pedersen O; Roeder M; Sneppen SB; Snorgaard O; Tarnow L; Thorsteinsson B; Vaag A; Vestergaard H; Wetterslev J; Wiinberg N;
Diabetes Obes Metab; 2009 Apr; 11(4):315-22. PubMed ID: 19267709
[TBL] [Abstract][Full Text] [Related]
28. Switching from premixed insulin to basal-bolus insulin glargine plus rapid-acting insulin: the ATLANTIC study.
Mathieu C; Storms F; Tits J; Veneman TF; Colin IM
Acta Clin Belg; 2013; 68(1):28-33. PubMed ID: 23627191
[TBL] [Abstract][Full Text] [Related]
29. HypoAware-a brief and partly web-based psycho-educational group intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycaemia: design of a cost-effectiveness randomised controlled trial.
Rondags SM; de Wit M; van Tulder MW; Diamant M; Snoek FJ
BMC Endocr Disord; 2015 Aug; 15():43. PubMed ID: 26292674
[TBL] [Abstract][Full Text] [Related]
30. Insights into optimal basal insulin titration in type 2 diabetes: Results of a quantitative survey.
Berard L; Bonnemaire M; Mical M; Edelman S
Diabetes Obes Metab; 2018 Feb; 20(2):301-308. PubMed ID: 28719066
[TBL] [Abstract][Full Text] [Related]
31. The value of episodic, intensive blood glucose monitoring in non-insulin treated persons with Type 2 Diabetes: design of the Structured Testing Program (STeP) study, a cluster-randomised, clinical trial [NCT00674986].
Polonsky W; Fisher L; Schikman C; Hinnen D; Parkin C; Jelsovsky Z; Amstutz L; Schweitzer M; Wagner R
BMC Fam Pract; 2010 May; 11():37. PubMed ID: 20482765
[TBL] [Abstract][Full Text] [Related]
32. Comparison of insulin glargine versus NPH insulin in people with Type 2 diabetes mellitus under outpatient-clinic conditions for 18 months using a basal-bolus regimen with a rapid-acting insulin analogue as mealtime insulin.
Siegmund T; Weber S; Blankenfeld H; Oeffner A; Schumm-Draeger PM
Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):349-53. PubMed ID: 17701878
[TBL] [Abstract][Full Text] [Related]
33. Structured patient education: the diabetes X-PERT Programme makes a difference.
Deakin TA; Cade JE; Williams R; Greenwood DC
Diabet Med; 2006 Sep; 23(9):944-54. PubMed ID: 16922700
[TBL] [Abstract][Full Text] [Related]
34. Automated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? [NCT01460446].
Cavan DA; Ziegler R; Cranston I; Barnard K; Ryder J; Vogel C; Parkin CG; Koehler W; Vesper I; Petersen B; Wagner RS
BMC Fam Pract; 2012 Oct; 13():102. PubMed ID: 23062116
[TBL] [Abstract][Full Text] [Related]
35. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial.
Miser WF; Arakaki R; Jiang H; Scism-Bacon J; Anderson PW; Fahrbach JL
Clin Ther; 2010 May; 32(5):896-908. PubMed ID: 20685497
[TBL] [Abstract][Full Text] [Related]
36. Comparable efficacy with similarly low risk of hypoglycaemia in patient- vs physician-managed basal insulin initiation and titration in insulin-naïve type 2 diabetic subjects: The Italian Titration Approach Study.
Bonadonna RC; Giaccari A; Buzzetti R; Perseghin G; Cucinotta D; Avogaro A; Aimaretti G; Larosa M; Fanelli CG; Bolli GB
Diabetes Metab Res Rev; 2020 Sep; 36(6):e3304. PubMed ID: 32118347
[TBL] [Abstract][Full Text] [Related]
37. Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.
Waugh N; Cummins E; Royle P; Clar C; Marien M; Richter B; Philip S
Health Technol Assess; 2010 Jul; 14(36):1-248. PubMed ID: 20646668
[TBL] [Abstract][Full Text] [Related]
38. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
[TBL] [Abstract][Full Text] [Related]
39. Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial.
Diamant M; Van Gaal L; Stranks S; Northrup J; Cao D; Taylor K; Trautmann M
Lancet; 2010 Jun; 375(9733):2234-43. PubMed ID: 20609969
[TBL] [Abstract][Full Text] [Related]
40. Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial).
Lind M; Hirsch IB; Tuomilehto J; Dahlqvist S; Ahrén B; Torffvit O; Attvall S; Ekelund M; Filipsson K; Tengmark BO; Sjöberg S; Pehrsson NG
BMJ; 2015 Oct; 351():h5364. PubMed ID: 26512041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
